Antibiotic therapy for Shigella dysentery.

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Shigella dysentery is a significant global health concern, causing illness and mortality.
• While mild cases are self-limiting, severe Shigella dysentery often requires antibiotic intervention.
• Current antibiotic recommendations vary regionally due to differing sensitivities and potential side effects.

Purpose of the Study:

• To systematically evaluate the efficacy and safety of various antibiotics for treating Shigella dysentery.
• To synthesize evidence from randomized controlled trials to inform clinical practice.

Main Methods:

• A comprehensive search of multiple databases (Cochrane, MEDLINE, EMBASE, LILACS) and trial registries was conducted in June 2009.
• Eligibility criteria included randomized controlled trials of antibiotics for Shigella dysentery.
• Data extraction and quality assessment were performed independently by four authors, with risk ratios and confidence intervals calculated.

Main Results:

• Sixteen trials involving 1748 participants were included, spanning four decades.
• Limited evidence suggests antibiotics reduce diarrhea episodes in moderately severe illness.
• No single antibiotic class demonstrated superior efficacy, and heterogeneity in some comparisons affected confidence in results. All studied antibiotics were deemed safe.

Conclusions:

• Antibiotics are effective in shortening the duration of Shigella dysentery.
• Updated local antibiotic sensitivity data are crucial for guiding empiric treatment decisions.
• Further high-quality trials are necessary to assess antibiotic roles in severe Shigella dysentery and high-risk populations.